Liquidia Corp.
Key Metrics
Market Snapshot
About
Liquidia Corp. is a biopharmaceutical company focused on the development and commercialization of therapies for pulmonary arterial hypertension and other respiratory diseases. The company uses proprietary PRINT technology to design and manufacture precisely engineered drug particles. Liquidia is advancing treatments that aim to improve outcomes for patients with cardiopulmonary conditions.